Bone & Joint Hospital commonly does studies for rheumatoid arthritis, osteoarthritis, osteoporosis and lupus. We have worked with several companies including Biogen-Idec, Human Genome SCIENCES, Pfizer, Targeted Genetics, and Hoffman-LaRoche, Sulzer (Centerpulse) Orthopedics, Encore Orthopedics, SmithKline Beecham, Ortho Biotech, Searle, Merck, Bristol Myers Squibb, Centocor, Aventis, Amgen, Novartis, XOMA, Abbott, Eli Lilly, Genentech, Human Genome Services and Alza over the past years.

We have experience in clinical trials Phases I-IV, which spans early or first use in humans ( I ) to post-market safety follow-up studies ( IV ). We are currently working with a number of biologic IV infusion therapies, as well as a gene-therapy medication that is injected into a specific problem joint.